Thomas T. Vo bought $50k of NUTX
Chief Executive Officer at Nutex Health, Inc.. 72,478 shares at an average of $0.69, traded May 13, 2024, filed May 30, 2024.
Score components
- +25RoleCEO
- +7Trade size$50k at market
- -5Relative to holdingsUnder 1% of holdings (0.4%)
- +8Price context92% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -10.8%, 3m +227.7%, 6m +453.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001486189-24-000027, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 13, 2024 | POpen-market purchase Common Stockindirect: See note(2) | +17,330 | $0.69 | $12k | 18,005,515 | May 30, 2024 |
| May 28, 2024 | POpen-market purchase Common Stockindirect: See note(2) | +48,394 | $0.70 | $34k | 18,053,909 | May 30, 2024 |
| May 29, 2024 | POpen-market purchase Common Stockindirect: See note(2) | +3,768 | $0.68 | $2,562 | 18,057,677 | May 30, 2024 |
| May 30, 2024 | POpen-market purchase Common Stockindirect: See note(2) | +2,986 | $0.66 | $1,971 | 18,060,663 | May 30, 2024 |
Related signals
Other insiders at Nutex Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | NUTXsell Nutex Health, Inc. | Scott J Saunders director | $43k 203 shares | -34% | |
| 43Moderate | Nutex Health, Inc. | Warren Hosseinion President | $24k 252 shares | +3% | |
| 46Moderate | Nutex Health, Inc. | Frank E Jaumot director | $14k 150 shares | - | |
| 33Weak | Nutex Health, Inc. | Kelvin Spears director | $945 10 shares | +0% | |
| 38Weak | Nutex Health, Inc. | Pamela W. Montgomery Chief Legal Officer-Healthcare | $7,021 79 shares | +3% | |
| 43Moderate | NUTXbuy Nutex Health, Inc. | Jon Christian Bates Chief Financial Officer | $103k 750 shares | +15% | |
| 37Weak | NUTXbuy Nutex Health, Inc. | Jon Christian Bates Chief Financial Officer | $82k 1,000 shares | +26% | |
| 53Moderate | Nutex Health, Inc. | Jon Christian Bates Chief Financial Officer | $29k 1,350 shares | +146% | |
| 57Moderate | Nutex Health, Inc. | Joshua DeTillio Chief Operating Officer | $33k 1,875 shares | +64% | |
| 48Moderate | NUTXbuy Nutex Health, Inc. | Joshua DeTillio Chief Operating Officer | $11k 20,000 shares | +214% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.